Journal for ImmunoTherapy of Cancer (Nov 2020)

849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macrophages

Gert Storm,
Maarten Nijen Twilhaar,
Lucas Czentner Colomo,
Joanna Grabowska,
Alsya Affandi,
Katarina Olesek,
Hakan Kalay,
Rene van Nostrum,
Paul Crocker,
Yvette van Kooyk,
Joke den Haan

Affiliations

Gert Storm: 2Utrecht University, Utrecht, Netherlands
Maarten Nijen Twilhaar: 1Amsterdam UMC, Amsterdam, Netherlands
Lucas Czentner Colomo: 2Utrecht University, Utrecht, Netherlands
Joanna Grabowska: 1Amsterdam UMC, Amsterdam, Netherlands
Alsya Affandi: 1Amsterdam UMC, Amsterdam, Netherlands
Katarina Olesek: 1Amsterdam UMC, Amsterdam, Netherlands
Hakan Kalay: 1Amsterdam UMC, Amsterdam, Netherlands
Rene van Nostrum: 2Utrecht University, Utrecht, Netherlands
Paul Crocker: 3University of Dundee, Dundee, UK
Yvette van Kooyk: 1Amsterdam UMC, Amsterdam, Netherlands
Joke den Haan: 1Amsterdam UMC, Amsterdam, Netherlands

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0849
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal